Christopher D.

Senior Director, Global Auditing at Emergent BioSolutions

Christopher D. has extensive experience in the pharmaceutical industry, with a strong focus on quality assurance and compliance. Christopher is currently working at Emergent BioSolutions as the Senior Director of Global Auditing, where they are responsible for overseeing auditing activities on a global scale. Prior to that, Christopher held various senior director roles at Akorn Pharmaceuticals, where they were involved in corporate quality, aseptic processing, risk management, global quality remediation, and global quality compliance. Christopher also has experience as a senior manager at Baxter International Inc., managing global quality and compliance programs, and as a QA Manager at Astellas Pharma US, overseeing quality programs and audit activities for commercial products. Christopher's expertise in quality systems and regulatory compliance is further demonstrated through their role as an Associate Director of Quality Systems at ACADIA Pharmaceuticals Inc. Christopher also worked as a Quality Assurance Consultant at Pharmaceutical Validation Solutions and Harrigan & Associates. Christopher began their career at Teva Pharmaceuticals, where they held various quality positions. Overall, Christopher's work experience has provided him with a broad range of skills and knowledge in the field of pharmaceutical quality assurance and compliance.

Christopher D. has a B.S. degree in Physiology and Neuroscience from UC San Diego.

Links

Previous companies

Akorn logo
Acadia Pharmaceuticals logo
Teva Pharmaceutical Industries logo
Baxter logo

Org chart

Timeline

  • Senior Director, Global Auditing

    September, 2023 - present

  • Senior Director, Inspection Readiness And Compliance

    May, 2023

View in org chart